These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The frequency of Lewy bodies in a consecutive autopsy series. Lindboe CF; Hansen HB Clin Neuropathol; 1998; 17(4):204-9. PubMed ID: 9707335 [TBL] [Abstract][Full Text] [Related]
4. Lewy body densities in the entorhinal and anterior cingulate cortex predict cognitive deficits in Parkinson's disease. Kövari E; Gold G; Herrmann FR; Canuto A; Hof PR; Bouras C; Giannakopoulos P Acta Neuropathol; 2003 Jul; 106(1):83-8. PubMed ID: 12687392 [TBL] [Abstract][Full Text] [Related]
5. Distribution of cerebral amyloid deposition and its relevance to clinical phenotype in Lewy body dementia. Fujishiro H; Iseki E; Higashi S; Kasanuki K; Murayama N; Togo T; Katsuse O; Uchikado H; Aoki N; Kosaka K; Arai H; Sato K Neurosci Lett; 2010 Dec; 486(1):19-23. PubMed ID: 20851165 [TBL] [Abstract][Full Text] [Related]
6. Abeta deposition is associated with enhanced cortical alpha-synuclein lesions in Lewy body diseases. Pletnikova O; West N; Lee MK; Rudow GL; Skolasky RL; Dawson TM; Marsh L; Troncoso JC Neurobiol Aging; 2005; 26(8):1183-92. PubMed ID: 15917102 [TBL] [Abstract][Full Text] [Related]
7. Amyloid beta-peptide and the dementia of Parkinson's disease. Jendroska K; Lees AJ; Poewe W; Daniel SE Mov Disord; 1996 Nov; 11(6):647-53. PubMed ID: 8914090 [TBL] [Abstract][Full Text] [Related]
8. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study. Jellinger KA Acta Neuropathol; 2003 Sep; 106(3):191-201. PubMed ID: 12845452 [TBL] [Abstract][Full Text] [Related]
9. Cortical Lewy bodies and Aβ burden are associated with prevalence and timing of dementia in Lewy body diseases. Ruffmann C; Calboli FC; Bravi I; Gveric D; Curry LK; de Smith A; Pavlou S; Buxton JL; Blakemore AI; Takousis P; Molloy S; Piccini P; Dexter DT; Roncaroli F; Gentleman SM; Middleton LT Neuropathol Appl Neurobiol; 2016 Aug; 42(5):436-50. PubMed ID: 26527105 [TBL] [Abstract][Full Text] [Related]
10. Prevalence of amyloid-beta deposition in the cerebral cortex in Parkinson's disease. Mastaglia FL; Johnsen RD; Byrnes ML; Kakulas BA Mov Disord; 2003 Jan; 18(1):81-6. PubMed ID: 12518303 [TBL] [Abstract][Full Text] [Related]
11. Inverse relationship between cerebrovascular lesions and severity of lewy body pathology in patients with lewy body diseases. Ghebremedhin E; Rosenberger A; Rüb U; Vuksic M; Berhe T; Bickeböller H; de Vos RA; Thal DR; Deller T J Neuropathol Exp Neurol; 2010 May; 69(5):442-8. PubMed ID: 20418782 [TBL] [Abstract][Full Text] [Related]
12. Cortical Lewy bodies and Alzheimer-type changes in patients with Parkinson's disease. Mattila PM; Röyttä M; Torikka H; Dickson DW; Rinne JO Acta Neuropathol; 1998 Jun; 95(6):576-82. PubMed ID: 9650749 [TBL] [Abstract][Full Text] [Related]
13. Cognitive status correlates with neuropathologic stage in Parkinson disease. Braak H; Rüb U; Jansen Steur EN; Del Tredici K; de Vos RA Neurology; 2005 Apr; 64(8):1404-10. PubMed ID: 15851731 [TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein E epsilon4 allele and progression of cortical Lewy body pathology in Parkinson's disease. Wakabayashi K; Kakita A; Hayashi S; Okuizumi K; Onodera O; Tanaka H; Ishikawa A; Tsuji S; Takahashi H Acta Neuropathol; 1998 May; 95(5):450-4. PubMed ID: 9600590 [TBL] [Abstract][Full Text] [Related]
16. Cortical alpha-synuclein load is associated with amyloid-beta plaque burden in a subset of Parkinson's disease patients. Lashley T; Holton JL; Gray E; Kirkham K; O'Sullivan SS; Hilbig A; Wood NW; Lees AJ; Revesz T Acta Neuropathol; 2008 Apr; 115(4):417-25. PubMed ID: 18185940 [TBL] [Abstract][Full Text] [Related]
17. Relationships between age and late progression of Parkinson's disease: a clinico-pathological study. Kempster PA; O'Sullivan SS; Holton JL; Revesz T; Lees AJ Brain; 2010 Jun; 133(Pt 6):1755-62. PubMed ID: 20371510 [TBL] [Abstract][Full Text] [Related]
18. Familial parkinsonism and dementia with ballooned neurons, argyrophilic neuronal inclusions, atypical neurofibrillary tangles, tau-negative astrocytic fibrillary tangles, and Lewy bodies. Mizutani T; Inose T; Nakajima S; Kakimi S; Uchigata M; Ikeda K; Gambetti P; Takasu T Acta Neuropathol; 1998 Jan; 95(1):15-27. PubMed ID: 9452818 [TBL] [Abstract][Full Text] [Related]
19. Dementia with Lewy bodies and Parkinson's disease with dementia: are they different? Tsuboi Y; Dickson DW Parkinsonism Relat Disord; 2005 Jun; 11 Suppl 1():S47-51. PubMed ID: 15885629 [TBL] [Abstract][Full Text] [Related]
20. Subcortical neurofibrillary tangles and argyrophilic grains in a case of familial frontotemporal dementia with parkinsonism. Kobayashi K; Sudo S; Matsubara R; Nakano H; Koshino Y Parkinsonism Relat Disord; 2008 Aug; 14(6):513-6. PubMed ID: 18346925 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]